Vaccines for preventing Ebola virus disease

Rebecca Kuehn; Hannah Ryan; Kevin C Okwaraeke; Susan Gould; Marty Chaplin; Matthew Riley; Lance Turtle; Shevin T Jacob; Tom Fletcher

doi:10.1002/14651858.CD015828

Vaccines for preventing Ebola virus disease

Cochrane Database Syst Rev. 2024 Nov 19;11(11):CD015828. doi: 10.1002/14651858.CD015828.

Authors

Rebecca Kuehn¹, Hannah Ryan², Kevin C Okwaraeke³, Susan Gould⁴, Marty Chaplin¹, Matthew Riley⁴, Lance Turtle^{5

6}, Shevin T Jacob¹, Tom Fletcher¹

Affiliations

¹ Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
² Department of Clinical Pharmacology, Royal Liverpool University Hospital, Liverpool, UK.
³ Research, The Alliance for International Medical Action (ALIMA), Owo, Nigeria.
⁴ Royal Liverpool University Hospital, Liverpool, UK.
⁵ NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
⁶ The Pandemic Institute, University of Liverpool, Liverpool, UK.

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of vaccines to prevent Ebola virus disease in people who have been, or have potentially been, exposed to Ebola virus.

MeSH terms

Ebola Vaccines* / therapeutic use
Ebolavirus / immunology
Hemorrhagic Fever, Ebola* / prevention & control
Humans
Randomized Controlled Trials as Topic

Substances

Ebola Vaccines